Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 9 September 2020
Kuros Biosciences's licensee Checkmate Pharmaceuticals completes its IPO on NASDAQ
Press Release, 1 September 2020
Kuros Biosciences Announces Treatment of the First Patient in its Spinal Fusion Trial with Fibrin-PTH
Kuros Interim Results, 2020
English version
Press Release, 12 August 2020
Kuros Biosciences Reports Results for First Half 2020
Press Release, 22 July 2020
Kuros Biosciences further strengthens orthobiologics patent portfolio
Minutes of the AGM, 21 April 2020
German version